|
Video: What is a Stock Split?
|
|
ChromaDex is a global bioscience company dedicated to healthy aging. Co. has the following three reportable segments: Consumer Products, which provides finished dietary supplement products; Ingredients, which provides Niagen® in ingredient form to its partners, as well as Immulina®, a spirulina extract with predominant active compounds of Braun-type lipoproteins which are useful for supporting human immune function; and Analytical Reference Standards and Services, which provides the supply of phytochemical reference standards and other research and development services and research services for customers exploring the frontier of natural product research and development. According to our ChromaDex stock split history records, ChromaDex has had 1 split. | |
|
ChromaDex (CDXC) has 1 split in our ChromaDex stock split history database. The split for CDXC took place on April 13, 2016. This was a 1 for 3 reverse split, meaning for each 3 shares of CDXC owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 333.333333333333 share position following the split.
When a company such as ChromaDex conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the ChromaDex stock split history from start to finish, an original position size of 1000 shares would have turned into 333.333333333333 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into ChromaDex shares, starting with a $10,000 purchase of CDXC, presented on a split-history-adjusted basis factoring in the complete ChromaDex stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/28/2014 |
|
End date: |
04/24/2024 |
|
Start price/share: |
$4.05 |
|
End price/share: |
$3.40 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-16.05% |
|
Average Annual Total Return: |
-1.73% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$8,399.05 |
|
Years: |
10.00 |
|
|
|
Date |
Ratio |
04/13/2016 | 1 for 3 |
|
|